GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
48.74
-2.20 (-4.32%)
At close: Oct 28, 2026, 4:00 PM EDT
48.81
+0.07 (0.14%)
After-hours: Oct 28, 2026, 7:54 PM EDT

GSK Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Equivalents
2,9343,1053,4423,3973,2963,5994,4643,8703,1922,9622,7902,9363,1773,1402,8903,7233,6066,46510,9674,274
Short-Term Investments
281191020212120211,305423,5061144,085673,555673,010614
Trading Asset Securities
---15---75---2,302-3,250-4,252---77
Cash & Short-Term Investments
2,9623,1063,4433,4213,3063,6194,4853,9663,2122,9834,0955,2806,6836,5046,9758,0427,1616,53213,9774,965
Cash Growth (YoY)
-10.41%-14.17%-23.23%-13.74%2.93%21.32%9.52%-24.89%-51.94%-54.14%-41.29%-34.34%-6.68%-0.43%-50.10%61.97%103.78%83.38%190.16%-27.36%
Accounts Receivable
8,2237,7067,7565,9137,9377,3217,0595,5637,3837,2596,8315,9058,5446,7766,8335,4527,5086,4578,3006,246
Other Receivables
3023681811,4503673764421,3654845194601,4893303192961,6525864134971,214
Receivables
8,5258,0747,9377,3748,3047,6977,5016,9357,8677,7787,2917,4038,8747,0957,1297,1158,0946,8708,7977,478
Inventory
6,3006,2826,1575,9246,1186,0726,0005,6695,9185,8595,7025,4985,4805,5125,3555,1464,6594,6646,0035,783
Prepaid Expenses
---385---390---355---343---315
Other Current Assets
10897224406114285993730114411710820323726012333536,122211133
Total Current Assets
17,89517,55917,76117,51017,84217,67318,08516,99717,29816,76417,20518,64421,24019,34819,71920,76920,24954,18828,98818,674
Property, Plant & Equipment
10,12210,03210,03810,04810,1329,9189,97110,0739,7259,8239,8679,9579,4549,3159,4149,6209,6509,15310,70410,672
Long-Term Investments
8639559581,1261,0839771,0321,1961,1041,1521,2771,1921,1421,3501,3401,5411,6421,7391,7552,276
Goodwill
8,2167,3817,2877,0187,1176,7346,9266,9826,6806,9606,9786,8116,9736,7166,8577,0467,1955,90610,70510,552
Other Intangible Assets
25,17216,80218,13816,74816,86515,37616,25815,51515,01015,47315,66714,76815,29515,53114,16014,31815,58911,37130,46830,079
Long-Term Deferred Tax Assets
6,7356,3396,3076,5206,1686,5816,4106,7576,2886,1665,8636,0495,6105,7995,6105,6584,8184,9525,2635,218
Other Long-Term Assets
2,6962,6702,3802,1482,1321,9992,0231,9431,9441,7281,6541,5841,1481,4021,4961,1941,1701,7361,8061,632
Total Assets
71,69961,73862,86961,11861,33959,25860,70559,46358,04958,06658,51159,00560,86259,46158,59660,14660,31389,04589,68979,103

Liabilities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Accounts Payable
15,63314,34214,2103,53514,55113,64813,8403,46213,47313,32713,7073,71814,69213,10113,2803,86614,90613,64816,5374,535
Accrued Expenses
---4,353---3,881---3,911---3,960---4,864
Short-Term Debt
-4,2912431,078537275213-164832028152,5203,6352,5791,4897931,027202707
Current Portion of Long-Term Debt
2,001-4,8011,7972,3191,7751,7452,1812,6513,2832,4141,8422,3232,2861,6822,2962,0002,3003,9002,691
Current Portion of Leases
---137---168---156---167---203
Current Income Taxes Payable
678524555498324581628703568731720500286544424471129295783489
Current Unearned Revenue
---153---171---222---299---307
Other Current Liabilities
2,4082,3772,6209,8403,6034,1004,40511,1314,6032,9212,8039,9042,5692,5422,73110,2623,12520,5652,8569,874
Total Current Liabilities
20,72021,53422,42921,39121,33420,37820,83121,69721,45920,34519,84621,06822,39022,10820,69622,81020,95337,83524,27823,670
Long-Term Debt
21,80114,00214,06814,08214,89415,30416,47413,70313,24413,57715,15614,15415,99315,55316,64416,19419,32218,78529,24919,761
Long-Term Leases
---693---934---1,051---841---812
Long-Term Unearned Revenue
---121---165---254---83---85
Pension & Post-Retirement Benefits
1,5521,6181,6951,6871,6631,7521,8701,8642,0282,2432,3062,3402,2782,3372,4802,5792,9282,5262,9403,113
Long-Term Deferred Tax Liabilities
1,6703032922913903844043822942902883114025002902893641493,6683,556
Other Long-Term Liabilities
7,5947,1046,9636,8977,3067,0867,4727,6327,5717,8417,6867,0327,1806,8047,1747,2548,0307,1106,9226,764
Total Liabilities
53,33744,56145,44745,16245,58744,90447,05146,37744,59644,29645,28246,21048,24347,30247,28450,05051,59766,40567,05757,761

Shareholders' Equity

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Common Stock
1,3491,3491,3491,3491,3491,3491,3491,3481,3481,3481,3481,3481,3481,3481,3481,3471,3471,3471,3471,347
Additional Paid-In Capital
3,5073,5073,5063,4983,4863,4863,4843,4733,4733,4723,4713,4513,4503,4503,4493,4403,4403,4393,4363,301
Retained Earnings
12,45811,46411,59010,95710,0168,7978,3078,7678,1878,5837,9357,7437,0176,4185,6554,7922,5929,8249,6378,747
Comprehensive Income & Other
1,4401,3251,4075731,2971,1591,017831,0009691,0868051,3181,4751,3681,0191,7731,7641,7611,660
Total Common Equity
18,75417,64517,85216,37716,14814,79114,15713,67114,00814,37213,84013,34713,13312,69111,82010,5989,15216,37416,18115,055
Minority Interest
-392-468-430-421-396-437-503-585-555-602-611-552-514-532-508-502-4366,2666,4516,287
Shareholders' Equity
18,36217,17717,42215,95615,75214,35413,65413,08613,45313,77013,22912,79512,61912,15911,31210,0968,71622,64022,63221,342
Total Liabilities & Equity
71,69961,73862,86961,11861,33959,25860,70559,46358,04958,06658,51159,00560,86259,46158,59660,14660,31389,04589,68979,103

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Total Debt
23,80218,29319,11217,78717,75017,35418,43216,98616,05916,94317,77218,01820,83621,47420,90520,98722,11522,11233,35124,174
Net Cash (Debt)
-20,840-15,187-15,669-14,366-14,444-13,735-13,947-13,020-12,847-13,960-13,677-12,738-14,153-14,970-13,930-12,945-14,954-15,580-19,374-19,209
Net Cash Growth (YoY)
--------------------
Net Cash Per Share
-5.12-3.74-3.85-3.52-3.52-3.34-3.37-3.14-3.10-3.39-3.33-3.09-3.44-3.66-3.41-3.16-3.66-3.83-4.76-4.73
Filing Date Shares Outstanding
4,0094,0074,0204,0134,0264,0474,0844,0814,0804,0794,0784,0564,0564,0534,0524,0344,0344,0264,0244,007
Total Common Shares Outstanding
4,0094,0074,0204,0134,0264,0474,0844,0814,0804,0794,0784,0564,0564,0534,0524,0344,0344,0264,0244,007
Working Capital
-2,825-3,975-4,668-3,881-3,492-2,705-2,746-4,700-4,161-3,581-2,641-2,424-1,150-2,760-977-2,041-70416,3534,710-4,996
Book Value Per Share
4.684.404.444.084.013.653.473.353.433.523.393.293.243.132.922.632.274.074.023.76
Tangible Book Value
-14,634-6,538-7,573-7,389-7,834-7,319-9,027-8,826-7,682-8,061-8,805-8,232-9,135-9,556-9,197-10,766-13,632-903-24,992-25,576
Tangible Book Value Per Share
-3.65-1.63-1.88-1.84-1.95-1.81-2.21-2.16-1.88-1.98-2.16-2.03-2.25-2.36-2.27-2.67-3.38-0.22-6.21-6.38
Land
---5,828---6,116---6,218---6,388---6,948
Machinery
---11,133---10,641---10,344---10,481---11,302
Construction In Progress
---2,508---2,314---2,092---1,808---1,707
SEC Filings: 10-K · 10-Q